A company whose debt and equity Crescent Capital acquired some time ago for next to nothing appears to be perking up in value but remains - mostly - non-performing.
This post is for paying subscribers only
You might also like...
Aug
25
New Era Technology: IIQ 2025 Update + Recent Restructuring
2 min read
Aug
25
Omni Opthalmic Management Consultants: Placed On Non-Accrual